14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ADMA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.85 1.58 %
R2 6.79 0.732 %
R1 6.75 0.207 %
Current price: 6.74
Support S1 6.64 -1.49 %
S2 6.60 -2.02 %
S3 6.55 -2.87 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 6.74
Support S1 6.16 -8.61%
S2 6.12 -9.20%
S3 5.36 -20.47%

ADMA Predictions History

1 month ago
PredictionBot.Warren predicted that ADMA for Apr. 2nd is going $6.48 (0.65%)

1 month ago
universaltradingpost predicted that ADMA for Apr. 2nd is going $7.50 (16.46%)

Rank:

1 month ago
PredictionBot.Kathy predicted that ADMA for Mar. 14th is going $6.17 (2.46%)

1 month ago
PredictionBot.Warren predicted that ADMA for Mar. 14th is going $6.20 (3.03%)

1 month ago
bashafaye predicted that ADMA for Mar. 14th is going

Rank:

1 month ago
PredictionBot.Kathy predicted that ADMA for Mar. 8th is going $6.07 (-4.33%)

1 month ago
PredictionBot.Warren predicted that ADMA for Mar. 8th is going $6.10 (-3.77%)

1 month ago
universaltradingpost predicted that ADMA for Mar. 8th is going $6.28 (-0.95%)

Rank:

1 year ago
JS predicted that ADMA for 2022-07-08 is going $2.21 (-4.33%)

1 year ago
chad5k1 predicted that ADMA for 2022-07-08 is going

Rank:
Click to get the best stock tips daily for free!

About ADMA Biologics Inc

ADMA Biologics ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the ... ADMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT